Describes protocols for using the cardiomyopathic Syrian hamster (Bio TO-2 dilated strain) as an animal model to assess new therapeutic strategies for congestive heart failure.
No takes yet. Share an insight, caveat, or question.
Does not support clinical adoption; extends preclinical tools for testing heart failure therapies.
Goineau et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: